The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer

Biological Psychology

Volumn 69, Issue 1 SPEC. ISS., 2005, Pages 85-96

  Mills, Paul J ^a,d,e   Parker, Barbara ^b,d,f   Dimsdale, Joel E ^a,d,e   Sadler, Georgia Robins ^c,d   Ancoli Israel, Sonia ^a,d,e,f  

^a UCSD MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Vet Aff S Diego Healthcare System   (United States)

Author keywords

Breast cancer; Chemotherapy; Depression; Fatigue; IL 6; Quality of life; sICAM 1; VEGF

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; DEPRESSION; FATIGUE; FEMALE; HUMAN; INFLAMMATION; MULTIPLE REGRESSION; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 14544304524     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2004.11.007     Document Type: Article

References (47)

1. M. Altomonte, E. Fonsatti, E. Lamaj, I. Cattarossi, A. Cattelan, and M. Maio Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesions Breast Cancer Research and Treatment 58 1999 19 23
2. Ancoli-Israel The relationship between fatigue and sleep in cancer patients: a review European Journal of Cancer Care 10 2001 245 255
3. I. Benoy, R. Salgado, C. Colpaert, R. Weytjens, P.B. Vermeulen, and L.Y. Dirix Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients Clinical Breast Cancer 2 2002 311 315
4. J.Y. Blay, S. Negrier, V. Combaret, S. Attali, E. Goillot, Y. Merrouche, A. Mercatello, A. Ravault, J.M. Tourani, and J.F. Moskovtchenko Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma Cancer Research 52 1992 3317 3322
5. K.S. Blesch, J.A. Paice, R. Wickham, N. Harte, D.K. Schnoor, S. Purl, M. Rehwalt, P.L. Kopp, S. Manson, and S.B. Coveny Correlates of fatigue in people with breast or lung cancer Oncology Nursing Forum 18 1991 81 87
6. J. Bonneterre, H. Roche, P. Kerbrat, A. Bremond, P. Fumoleau, M. Namer, M.J. Goudier, S. Schraub, P. Fargeot, and I. Chapelle-Marcillia French adjuvant study group 05 (FEC 50 vs FEC 100): 10-year update of benefit/risk ration after adjuvant chemotherapy (CT) in node-positive (N+), early breast cancer (EBC) patients (pts.) Proceedings of the American Society on Clinical Oncology 2003 93
7. N. Boudreau, and C. Myers Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment Breast Cancer Research 5 2002 140 144
8. J.E. Bower, P.A. Ganz, N. Aziz, and J.L. Fahey Fatigue and proinflammatory cytokine activity in breast cancer survivors Psychosomatic Medicine 64 2002 604 611
9. M.J. Brady, D.F. Cella, F. Mo, A.E. Bonomi, D.S. Tulsky, S.R. Lloyd, S. Deasy, M. Cobleigh, and G. Shiomoto Reliability and validity of the Functional Assessment of Cancer Therapy-B (FACT-B) quality of life instrument Journal of Clinical Oncology 15 1997 974 986
10. D.F. Cella Quality of life outcomes: measurement and validation Oncology 10 1996 233 246
11. B. Dankbar, T. Padro, R. Leo, B. Feldmann, M. Kropff, R.M. Mesters, H. Serve, W.E. Berdel, and J. Kienast Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma Blood 95 2000 2630 2636
12. N. de Jong, A.M. Courtens, H.H. Abu-Saad, and H.C. Schouten Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature Cancer Nursing 25 2002 283 297
13. L. Fayad, M.J. Keating, J.M. Reuben, S. O'Brien, B.N. Lee, S. Lerner, and R. Kurzrock Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome Blood 97 2001 256 263
14. G. Gasparini Prognostic value of vascular endothelial growth factor in breast cancer Oncologist 5 2000 37 44
15. H. Geinitz, F.B. Zimmermann, P. Stoll, R. Thamm, W. Kaffenberger, K. Ansorg, M. Keller, R. Busch, R. Busch, D. van Beuningen, and M. Molls Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer International Journal of Radiation Oncology Biology Physics 51 2001 691 698
16. D. Hutchins, and C.M. Steel Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors International Journal of Cancer 58 1994 180 184
17. B. Klein, I. Levin, B. Kfir, M. Mishaeli, J. Shapira, and T. Klein The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients Tumour Biology 16 1995 290 296
18. W.J. Kostler, S. Tomek, T. Brodowicz, A.C. Budinsky, M. Flamm, M. Hejna, M. Krainer, C. Wiltschke, and C.C. Zielinski Soluble ICAM-1 in breast cancer: clinical significance and biological implications Cancer Immunology Immunotherapy 50 2001 483 490
19. S.J. Larson, and A.J. Dunn Behavioral effects of cytokines Brain Behavior and Immunity 15 2001 371 387
20. S.K. Lutgendorf, E.L. Johnsen, B. Cooper, B. Anderson, J.I. Sorosky, R.E. Buller, and A.K. Sood Vascular endothelial growth factor and social support in patients with ovarian carcinoma Cancer 95 2002 808 815
21. U.R. Malik, D.F. Makower, and S. Wadler Interferon-mediated fatigue Cancer 92 2001 1664 1668
22. M. Melis, E. Pace, L. Siena, M. Spatafora, A. Tipa, M. Profita, A. Bonanno, A.M. Vignola, G. Bonsignore, C.H. Mody, and M. Gjomarkaj Biologically active ICAM-1 is shed as dimers by a regulated mechanism in the inflamed pleural space American Journal of Respiratory and Critical Care Medicine 167 2003 1131 1138
23. D.B. Mendel, A.D. Laird, X. Xin, S.G. Louie, J.G. Christensen, G. Li, R.E. Schreck, T.J. Abrams, T.J. Ngai, L.B. Lee, L.J. Murray, J. Carver, E. Chan, K.G. Moss, J.O. Haznedar, J. Sukbuntherng, R.A. Blake, L. Sun, C. Tang, T. Miller, S. Shirazian, G. McMahon, and J.M. Cherrington In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship Clinical Cancer Research 9 2003 327 337
24. R.A. Merendino, S. Gangemi, A. Ruello, A. Bene, E. Losi, G. Lonbardo, and F. Purello-Dambrosio Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations International Journal of Biological Markers 16 2001 126 129
25. P.J. Mills, C.J. Perez, K.A. Adler, and M.G. Ziegler Leukocyte and endothelial cell adhesion molecule expression and adrenergic receptors and agonists following spaceflight Journal of Neuroimmunology 132 2002 173 179
26. P.J. Mills, N.H. Farag, C. Hong, B.P. Kennedy, C.C. Berry, and M.G. Ziegler Immune cell CD62l and CD11a expression in response to a psychological stressor in human hypertension Brain Behavior and Immunity 17 2003 260 267
27. P.J. Mills, and J.E. Dimsdale Sleep apnea: a model for studying cytokines, sleep, and sleep disruption Brain Behavior and Immunity 18 2004 298 303
28. P.J. Mills, B. Parker, V. Jones, K.A. Adler, C. Perez, S. Johnson, M. Cohen-Zion, M. Marler, G.R. Sadler, J.E. Dimsdale, and S. Ancoli-Israel The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and VEGF levels in breast cancer Clinical Cancer Research 10 2004 4998 5003
29. C.R. Miranda, C.N. de Resende, C.F. Melo, A.L. Costa Jr., and H. Friedman Depression before and after uterine cervix and breast cancer neoadjuvant chemotherapy International Journal of Gynecological Cancer 12 2002 773 776
30. J.M. Nabholtz, T. Pienkowski, J. Mackey, M. Pawlicki, J.P. Guastafia, C. Vogel, C. Eaver, B. Walley, M. Martin, L. Chap, E. Tomiak, E. Juhos, R. Guevin, A. Howell, J. Hainsworth, T. Fornander, S. Blitz, S. Gazel, C. Loret, and A. Riva Phase III trial comparing TAC (docetaxol, doxorubicin, cyclophosphamide) with FAC (5-fluorouracil, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer Proceedings of the American Society on Clinical Oncology 2003 141
31. R. Nishimura, K. Nagao, H. Miyayama, M. Matsuda, K. Baba, H. Yamashita, and M. Fukuda Higher plasma vascular endothelial growth factor levels correlate with menopause, overexpression of p53, and recurrence of breast cancer Breast Cancer 10 2000 120 128
32. D.M. O'Hanlon, H. Fitzsimons, J. Lynch, S. Tormey, C. Malone, and H.F. Given Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma European Journal of Cancer 38 2002 2252 2257
33. L. Pusztai, T.R. Mendoza, J.M. Reuben, M.M. Martinez, J.S. Willey, J. Lara, A. Syed, H.A. Fritsche, E. Bruera, D. Booser, V. Valero, B. Arun, N. Ibrahim, E. Rivera, M. Royce, C.S. Cleeland, and G.N. Hortobagyi Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy Cytokine 25 2004 94 102
34. L.S. Radloff The CES-D scale: a self-report depression scale for research in the general population Applied Psychological Measurement 1 1977 385 401
35. J.A. Roscoe, G.R. Morrow, J.T. Hickok, P. Bushunow, S. Matteson, D. Rakita, and P.L. Andrews Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment Support Care Cancer 10 2001 29 36
36. E.M.A. Smets, B. Garssen, A. Cull, and J.C. de Haes Application of the multidimensional fatigue inventory in cancer patients receiving radiotherapy British Journal of Cancer 73 1996 241 245
37. K.D. Stein, P.B. Jacobsen, C.M. Blanchard, and C.T. Thors Further validation of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) Journal Pain Symptom Management 27 2004 14 23
38. K.D. Stein, S.C. Martin, D.M. Hann, and P.B. Jacobsen A multidimensional measure of fatigue for use with cancer patients Cancer Practice 6 1998 143 152
39. M. Vasse, D. Thibout, J. Paysant, E. Legrand, C. Soria, and M. Crepin Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules British Journal of Cancer 84 2001 802 807
40. H.M. Verheul, K. Hoekman, S. Luykx-de Bakker, C.A. Eekman, C.C. Folman, H.J. Broxterman, and H.M. Pinedo Platelet: transporter of vascular endothelial growth factor Clinical Cancer Research 3 1997 2187 2190
41. M.S. Vuoristo, S. Laine, H. Huhtala, L.M. Parvinen, M. Hahka-Kemppinen, M. Korpela, E. Kumpulainen, and P. Kellokumpu-Lehtinen Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma European Journal of Cancer 37 2001 1629 1634
42. X. Wang, C. Clowes, R. Duarte, and Q.Q. Pu Serum ICAM-1 concentrations following conventional dose consolidation chemotherapy for acute myeloid leukemia and after high dose chemotherapy with autologous haematopoietic stem cell rescue International Journal of Oncology 17 2000 591 595
43. T.E. Weaver, A.M. Laizner, L.K. Evans, G. Maislin, D.K. Chugh, K. Lyon, P.L. Smith, A.R. Schwartz, S. Redline, A.I. Pack, and D.F. Dinges An instrument to measure functional status outcome for disorders of excessive sleepiness Sleep 20 1999 835 843
44. M.L. Winningham, L.M. Nail, M.B. Burke, L. Brophy, B. Cimprich, L.S. Jones, S. Pickard-Holley, V. Rhodes, B. St. Pierre, S. Beck, E.C. Glass, V.L. Mock, K.H. Mooney, and B. Piper Fatigue and the cancer experience; the state of the knowledge Oncology Nursing Forum 21 1994 23 36
45. Y. Wu, L. Saldana, R. Chillar, and J.V. Vadgama Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment International Journal of Oncology 20 2002 509 516
46. B.Y. Yellen, D.F. Cella, K. Webster, C. Blendowski, E. Kaplan, and B. Sarokhan Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system Journal of Pain and System Management 13 1997 63 74
47. G.J. Zhang, and I. Adachi Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis International Journal of Oncology 14 1999 71 77